NICE consults on expensive blood cancer treatment

NICE has invited comments and further evidence on a new treatment for aggressive subtypes of non-Hodgkin lymphoma called diffuse large B-cell lymphoma and primary mediastinal B-cell lymphoma that could lead to it being made available for use on the NHS.
Source: NHS Networks - Category: UK Health Source Type: news